Education
About Us
Working with TipRanks
Follow Us
Precision BioSciences (DTIL)
NASDAQ:DTIL
Total Valuation
Precision BioSciences has a market cap or net worth of $57.86M. The enterprise value is -$25.79M.
Market Cap$57.86M
Enterprise Value-$25.79M
Share Statistics
Precision BioSciences has 10.48M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10.48M
Owned by Insiders3.50%
Owned by Instutions0.84%
Financial Efficiency
Precision BioSciences’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 5.78%.
Return on Equity (ROE)12.71%
Return on Assets (ROA)5.25%
Return on Invested Capital (ROIC)5.78%
Return on Capital Employed (ROCE)5.90%
Revenue Per Employee$636,074.074
Profits Per Employee$66,361.111
Employee Count108
Asset Turnover0.50
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Precision BioSciences is 3.63. Precision BioSciences’s PEG ratio is -0.03.
PE Ratio3.63
PS Ratio0.38
PB Ratio0.46
Price to Fair Value0.46
Price to FCF-0.44
Price to Operating Cash Flow-0.45
PEG Ratio-0.03
Income Statement
In the last 12 months, Precision BioSciences had revenue of $68.70M and earned $7.17M in profits. Earnings per share was $1.64.
Revenue$68.70M
Gross Profit$64.88M
Operating Income-$26.16M
Pretax Income$7.17M
Net Income$7.17M
EBITDA13.53M
Earnings Per Share (EPS)1.64
Cash Flow
In the last 12 months, operating cash flow was -$58.45M and capital expenditures -$250.00K, giving a free cash flow of -$58.70M billion.
Operating Cash Flow-$58.45M
Free Cash Flow-$58.70M
Free Cash Flow per Share-$5.60
Dividends & Yields
Precision BioSciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-225.46%
Earnings Yield27.53%
Stock Price Statistics
Beta1.26
52-Week Price Change-53.17%
50-Day Moving Average5.03
200-Day Moving Average7.22
Relative Strength Index (RSI)52.71
Average Volume (3m)186.47K
Important Dates
Precision BioSciences upcoming earnings date is May 7, 2025, After Close.
Last Earnings DateMar 26, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
Precision BioSciences as a current ratio of 6.34, with Debt / Equity ratio of 0.02
Current Ratio6.34
Quick Ratio6.34
Debt to Market Cap0.05
Net Debt to EBITDA-6.25
Interest Coverage Ratio4.02
Taxes
In the past 12 months, Precision BioSciences has paid $1.72K in taxes.
Income Tax$1.72K
Effective Tax Rate0.00%
Enterprise Valuation
Precision BioSciences EV to EBITDA ratio is -4.33, with an EV/FCF ratio of 1.00.
EV to Sales-0.85
EV to EBITDA-4.33
EV to Free Cash Flow1.00
EV to Operating Cash Flow1.00
Balance Sheet
Precision BioSciences has $86.31M in cash and marketable securities with $30.05M in debt, giving a net cash position of -$56.27M billion.
Cash & Marketable Securities$86.31M
Total Debt$30.05M
Net Cash-$56.27M
Net Cash Per Share-$5.37
Tangible Book Value Per Share$8.16
Margins
Gross margin is 100.00%, with operating margin of 10.43%, and net profit margin of 10.43%.
Gross Margin100.00%
Operating Margin10.43%
Pretax Margin10.43%
Net Profit Margin10.43%
EBITDA Margin19.69%
EBIT Margin13.03%
Analyst Forecast
The average price target for Precision BioSciences is $41.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$41.33
Price Target Upside723.31%
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast40.98%
EPS Growth Forecast